Clinical Study
Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
Table 1
Characteristics of patients receiving Goshajinkigan for peripheral neuropathy due to oxaliplatin-based chemotherapy for colorectal cancer.
| ||||||||||||||||||||||||||||||||||||||||||||
PS: performance status; GJG: Goshajinkigan; P: value; N.S.: not significant. |